4.7 Article

Harnessing NK cell-based immunotherapy to prevent the high-dose radiotherapy-inducing tumor survival recurrence

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biotechnology & Applied Microbiology

Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders

Nicholas A. Maskalenko et al.

Summary: NK cells play crucial roles in the innate immunosurveillance of cancer and viral infections. Our understanding of the basic biology of NK cells has greatly improved in the past few decades, leading to the development of exciting new therapeutics.

NATURE REVIEWS DRUG DISCOVERY (2022)

Review Oncology

Natural killer cells and immune-checkpoint inhibitor therapy: Current knowledge and new challenges

Alessandro Poggi et al.

Summary: The discovery of immune checkpoints and the development of specific blockers have revolutionized anti-cancer therapy. This review focuses on the potential of NK ICs as targets for dual-checkpoint inhibition, highlighting their role in NK cell survival and anti-tumor immune response.

MOLECULAR THERAPY-ONCOLYTICS (2022)

Article Multidisciplinary Sciences

Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8

Thomas Walle et al.

Summary: NK cells play a central role in the radiation-induced immune response, enhancing tumor control through the secretion of CXCL8/IL-8 and recruiting immune cells. This discovery suggests a rational cancer treatment strategy combining NK cells with radiotherapy.

SCIENCE ADVANCES (2022)

Review Biochemistry & Molecular Biology

NK cells and ILCs in tumor immunotherapy

Simona Sivori et al.

Summary: Innate immune cells, especially NK cells, play an important role in tumor immunotherapy by controlling tumor growth and metastasis. Various approaches have been developed, such as using IL-15 to improve NK cell function and utilizing NK cell engagers to activate NK cells. Additionally, NK cells may express inhibitory checkpoints like PD-1, which can be targeted for therapeutic use against certain tumors.

MOLECULAR ASPECTS OF MEDICINE (2021)

Article Oncology

Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery

Joe Y. Chang et al.

Summary: Long-term results from the revised STARS trial showed that survival after SABR is non-inferior to VATS L-MLND for operable stage IA NSCLC. SABR remains promising for such cases, with multidisciplinary management strongly recommended.

LANCET ONCOLOGY (2021)

Review Biotechnology & Applied Microbiology

NK cells for cancer immunotherapy

Noriko Shimasaki et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

Editorial Material Biochemistry & Molecular Biology

SnapShot: Natural Killer Cells

Adeline Crinier et al.

Review Immunology

NK Cell-Based Immune Checkpoint Inhibition

Muhammad Khan et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Oncology

Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma

Hampartsoum B. Barsoumian et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Review Immunology

NK Cell Dysfunction and Checkpoint Immunotherapy

Jiacheng Bi et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Immunology

Natural Killer Cells: Development, Maturation, and Clinical Utilization

Alex M. Abel et al.

FRONTIERS IN IMMUNOLOGY (2018)

Review Oncology

Radiotherapy and immunotherapy: a beneficial liaison?

Ralph R. Weichselbaum et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Article Multidisciplinary Sciences

Dendritic cell MST1 inhibits Th17 differentiation

Chunxiao Li et al.

NATURE COMMUNICATIONS (2017)

Review Radiology, Nuclear Medicine & Medical Imaging

LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective

S. Adebahr et al.

BRITISH JOURNAL OF RADIOLOGY (2015)

Article Medicine, General & Internal

Protons and more: state of the art in radiotherapy

P. J. Hoskin et al.

CLINICAL MEDICINE (2014)

Article Allergy

Natural killer cell biology: An update and future directions

Kerry S. Campbell et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)

Editorial Material Cardiac & Cardiovascular Systems

CD31: beyond a marker for endothelial cells

Li Liu et al.

CARDIOVASCULAR RESEARCH (2012)

Review Biochemistry & Molecular Biology

Natural Killer Cell Education and Tolerance

Mark T. Orr et al.

Article Biochemistry & Molecular Biology

Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research

Carol Kilkenny et al.

PLOS BIOLOGY (2010)

Review Immunology

Functions of natural killer cells

Eric Vivier et al.

NATURE IMMUNOLOGY (2008)

Article Biochemical Research Methods

CD107a as a functional marker for the identification of natural killer cell activity

G Alter et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2004)

Review Immunology

The biology of human natural killer-cell subsets

MA Cooper et al.

TRENDS IN IMMUNOLOGY (2001)